WikiJournalClub:High-priority articles: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
Line 8: Line 8:


===Incomplete or nonexistent===
===Incomplete or nonexistent===
* 2023 {{create article link|ENLIVEN}}: FGF21 analogue in NASH [https://www.nejm.org/doi/full/10.1056/NEJMoa2304286]
* 2023 {{create article link|Thalidomide for small intestine angiodysplasia}}: Thalidomide in angiodysplasia of the small intestine [https://www.nejm.org/doi/full/10.1056/NEJMoa2303706]
* 2023 {{create article link|Thalidomide for small intestine angiodysplasia}}: Thalidomide in angiodysplasia of the small intestine [https://www.nejm.org/doi/full/10.1056/NEJMoa2303706]
* 2023 {{create article link|STEP-HFpEF}}: GLP-1 agonist in HFpEF and obesity [https://www.nejm.org/doi/full/10.1056/NEJMoa2306963]
* 2023 {{create article link|STEP-HFpEF}}: GLP-1 agonist in HFpEF and obesity [https://www.nejm.org/doi/full/10.1056/NEJMoa2306963]
* 2023 {{create article link|ENLIVEN}}: FGF21 analogue in NASH [https://www.nejm.org/doi/full/10.1056/NEJMoa2304286]
* 2023 {{create article link|Clarity AD}}: Lecanemab in Alzheimer's disease [https://www.nejm.org/doi/full/10.1056/NEJMoa2212948]
* 2023 {{create article link|ARTESIA}}: Apixaban for stroke reduction in subclinical AF [https://www.nejm.org/doi/full/10.1056/NEJMoa2310234]
* 2023 {{create article link|AMIKINHAL}}: Inhaled amikacin to prevent ventilator-associated pneumonia [https://www.nejm.org/doi/full/10.1056/NEJMoa2310307]
* 2023 {{create article link|AMIKINHAL}}: Inhaled amikacin to prevent ventilator-associated pneumonia [https://www.nejm.org/doi/full/10.1056/NEJMoa2310307]
* 2023 {{create article link|ARTESIA}}: Apixaban for stroke reduction in subclinical AF [https://www.nejm.org/doi/full/10.1056/NEJMoa2310234]
* 2023 {{create article link|Clarity AD}}: Lecanemab in Alzheimer's disease [https://www.nejm.org/doi/full/10.1056/NEJMoa2212948]
* 2022 {{create article link|DESTINY-Breast04}}: Trastuzumab deruxtecan in previously treated HER2-Low breast cancer [https://www.nejm.org/doi/full/10.1056/NEJMoa2203690]
* 2022 {{create article link|DESTINY-Breast04}}: Trastuzumab deruxtecan in previously treated HER2-Low breast cancer [https://www.nejm.org/doi/full/10.1056/NEJMoa2203690]
* 2021 {{create article link|TOMAHAWK}}: Angiography for out of hospital cardiac arrest [https://www.nejm.org/doi/full/10.1056/NEJMoa2101909]
* 2021 {{create article link|TOMAHAWK}}: Angiography for out of hospital cardiac arrest [https://www.nejm.org/doi/full/10.1056/NEJMoa2101909]
Bots, editor, reviewer, Administrators
13,941

edits

Navigation menu